Page last updated: 2024-09-05

rwj 22108 and pilocarpine

rwj 22108 has been researched along with pilocarpine in 1 studies

Compound Research Comparison

Studies
(rwj 22108)
Trials
(rwj 22108)
Recent Studies (post-2010)
(rwj 22108)
Studies
(pilocarpine)
Trials
(pilocarpine)
Recent Studies (post-2010) (pilocarpine)
5007,3343401,528

Protein Interaction Comparison

ProteinTaxonomyrwj 22108 (IC50)pilocarpine (IC50)
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)3.0267
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)3.84
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)3.84
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)3.84
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)3.84

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, T; Anderson, DW; Capetola, RJ; Dodd, JH; Kirchner, T; Moore, JB; Ritchie, DM1

Other Studies

1 other study(ies) available for rwj 22108 and pilocarpine

ArticleYear
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker.
    International archives of allergy and immunology, 1993, Volume: 100, Issue:3

    Topics: Airway Obstruction; Airway Resistance; Animals; Antigens; Asthma; Bronchial Spasm; Bronchoconstriction; Calcium Channel Blockers; Consciousness; Dogs; Female; Gallopamil; Male; Nifedipine; Parasympatholytics; Pilocarpine; Pyridines; Sheep; SRS-A; Time Factors

1993